RecruitingPhase 4NCT05457972

Postpartum Vaginal Estrogen for Breastfeeding Patients

Postpartum Vaginal Estrogen for Sexual Function in Breastfeeding Patients: A Randomized Controlled Trial


Sponsor

University Hospitals Cleveland Medical Center

Enrollment

100 participants

Start Date

Feb 22, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Sexual dysfunction is very common in the postpartum period and is more common in people who breastfeed or pump. This research study was designed to help determine whether postpartum patients who use vaginal estrogen cream while breastfeeding have improved sexual function compared to postpartum patients who do not.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Estradiol and a medical device called Vaginal Moisturizer for people with breastfeeding, postpartum sexual dysfunction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEstradiol

Imvexxy is an FDA-approved drug produced by TherapeuticsMD.

DEVICEVaginal Moisturizer

Ingredients include hydrogenated coconut and palm oils and natural-source vitamin E (d-alpha tocopheryl acetate and tocopherols).


Locations(1)

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05457972


Related Trials